A Trial Comparing Efficacy and Safety of GZR101 and IDegAsp in Insulin Naïve or Insulin Treated Subjects with T2DM
Clinical trial NCT06199505 · COMPLETED
Trial details
- NCT number
- NCT06199505
- Sponsor
- Gan and Lee Pharmaceuticals, USA
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-21
- Primary completion
- 2024-06-28
- Enrollment
- 153
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.